Innovations in device design, energy delivery systems, and integration with surgical platforms have significantly improved the performance and adoption of these tools.
Modern vessel sealing devices incorporate advanced energy sources, such as bipolar radiofrequency and ultrasonic technologies, to achieve superior hemostasis. These technologies enable controlled energy delivery, minimizing thermal spread to surrounding tissues and reducing the risk of complications during surgery.
Additionally, the growing adoption of laparoscopic and robotic-assisted surgeries has driven the development of vessel-sealing devices compatible with these platforms. Compact and ergonomic designs, along with enhanced articulation and precision, make these devices indispensable in minimally invasive procedures.
The introduction of single-use vessel sealing devices has addressed concerns regarding infection control and cross-contamination. Moreover, hybrid devices that combine vessel sealing with cutting functions have streamlined surgical workflows, reducing the need for multiple instruments.
Authors:
Mariam Faizullabhoy , Gauri Wani
Frequently Asked Questions (FAQ) :
The global vessel sealing devices industry was valued at USD 3 billion in 2024 and is projected to grow at a 6% CAGR from 2025 to 2034, driven by the increasing demand for minimally invasive surgeries and the rising prevalence of chronic diseases.
The instruments segment generated USD 1.5 billion in revenue in 2024, supported by their extensive use in general, laparoscopic, and robotic-assisted surgeries.
The North America vessel sealing devices market recorded USD 1.3 billion in revenue in 2024 and is expected to grow at a 5.4% CAGR from 2025 to 2034, driven by advanced healthcare facilities and a high prevalence of chronic diseases requiring surgical interventions.
Key players in the market include B. Braun, Bolder Surgical, LLC, BOWA Medical, CONMED Corporation, Erbe Elektromedizin GmbH, Intuitive Surgical, Johnson & Johnson, KLS Martin Group, and Medtronic plc.